Next Article in Journal
Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia
Previous Article in Journal
A Better Cardiopulmonary Fitness Is Associated with Improved Concentration Level and Health-Related Quality of Life in Primary School Children
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Combined Coronary CT-Angiography and TAVI Planning: Utility of CT-FFR in Patients with Morphologically Ruled-Out Obstructive Coronary Artery Disease

by
Robin Fabian Gohmann
1,2,*,†,
Patrick Seitz
1,†,
Konrad Pawelka
1,2,
Nicolas Majunke
3,
Adrian Schug
1,2,
Linda Heiser
1,
Katharina Renatus
1,2,
Steffen Desch
3,
Philipp Lauten
3,
David Holzhey
4,
Thilo Noack
4,
Johannes Wilde
3,
Philipp Kiefer
4,
Christian Krieghoff
1,
Christian Lücke
1,
Sebastian Ebel
1,2,
Sebastian Gottschling
1,
Michael A. Borger
4,5,
Holger Thiele
3,5,
Christoph Panknin
6,
Mohamed Abdel-Wahab
3,
Matthias Horn
7,‡ and
Matthias Gutberlet
1,2,5,‡
add Show full author list remove Hide full author list
1
Department of Diagnostic and Interventional Radiology, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289 Leipzig, Germany
2
Medical Faculty, University of Leipzig, Liebigstr. 27, 04103 Leipzig, Germany
3
Department of Cardiology, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289 Leipzig, Germany
4
Department of Cardiac Surgery, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289 Leipzig, Germany
5
Leipzig Heart Institute, Russenstr. 69a, 04289 Leipzig, Germany
6
Siemens Healthcare GmbH, Henkestr. 127, 91052 Erlangen, Germany
7
Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Härtelstr. 16-18, 04107 Leipzig, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
These authors contributed equally to this work.
J. Clin. Med. 2022, 11(5), 1331; https://doi.org/10.3390/jcm11051331
Submission received: 9 January 2022 / Revised: 15 February 2022 / Accepted: 21 February 2022 / Published: 28 February 2022
(This article belongs to the Section Nuclear Medicine & Radiology)

Abstract

:
Background: Coronary artery disease (CAD) is a frequent comorbidity in patients undergoing transcatheter aortic valve implantation (TAVI). If significant CAD can be excluded on coronary CT-angiography (cCTA), invasive coronary angiography (ICA) may be avoided. However, a high plaque burden may make the exclusion of CAD challenging, particularly for less experienced readers. The objective was to analyze the ability of machine learning (ML)-based CT-derived fractional flow reserve (CT-FFR) to correctly categorize cCTA studies without obstructive CAD acquired during pre-TAVI evaluation and to correlate recategorization to image quality and coronary artery calcium score (CAC). Methods: In total, 116 patients without significant stenosis (≥50% diameter) on cCTA as part of pre-TAVI CT were included. Patients were examined with an electrocardiogram-gated CT scan of the heart and high-pitch scan of the torso. Patients were re-evaluated with ML-based CT-FFR (threshold = 0.80). The standard of reference was ICA. Image quality was assessed quantitatively and qualitatively. Results: ML-based CT-FFR was successfully performed in 94.0% (109/116) of patients, including 436 vessels. With CT-FFR, 76/109 patients and 126/436 vessels were falsely categorized as having significant CAD. With CT-FFR 2/2 patients but no vessels initially falsely classified by cCTA were correctly recategorized as having significant CAD. Reclassification occurred predominantly in distal segments. Virtually no correlation was found between image quality or CAC. Conclusions: Unselectively applied, CT-FFR may vastly increase the number of false positive ratings of CAD compared to morphological scoring. Recategorization was virtually independently from image quality or CAC and occurred predominantly in distal segments. It is unclear whether or not the reduced CT-FFR represent true pressure ratios and potentially signifies pathophysiology in patients with severe aortic stenosis.

1. Introduction

Coronary artery disease (CAD) is a frequent comorbidity in patients with severe aortic stenosis and is recommended to be excluded prior to transcatheter aortic valve implantation (TAVI) [1,2]. The exclusion of CAD has traditionally been undertaken via invasive coronary angiography (ICA); however, coronary computed angiography (cCTA) is now recommended to be considered as an alternative [1,3,4,5]. Numerous studies have confirmed the beneficial diagnostic profile of cCTA for the exclusion of CAD also in the cohort of patients considered for TAVI [6,7,8,9,10,11,12,13,14,15]. Noteworthy, when integrated as part of TAVI planning, cCTA may be performed without additional contrast medium and thus practically without additional risk to the patient [8]. However, the number of reported cCTAs before TAVI compared to the number of procedures performed seems disproportionately small [16]. This is striking as potentially any CT prior to TAVI performed in accordance with the guidelines [3] would be able to depict the coronary arteries technically robustly, and effectively constitute a cCTA.
A possible reason for the apparent reluctance to consistently report the coronary status prior to TAVI on CT may be the high plaque burden. Particularly, an elevated coronary artery calcium score (CAC) is likely to be a major contributing factor, being responsible for the high false positive rate and relatively low specificity of cCTA in this cohort [17]. CT-derived fractional flow reserve (CT-FFR) may increase the specificity and diagnostic accuracy, and has been described to do so also in patients prior to TAVI [18,19].
Furthermore, CT-FFR has been proposed to mitigate the apparent challenges in reading cCTA, when serving as a guide to morphological coronary analysis, improving interpretation speed and reader confidence, particularly for less experienced readers [20]. However, commercially available off-site solutions to CT-FFR are impractical for this purpose, as they require several hours for processing and are also costly [21,22,23]. Newer approaches to CT-FFR, namely those based on machine learning (ML), are much less computationally demanding and can be calculated on site in just a few seconds [24]. The results rendered by such newer algorithms are comparable to the more conventional approach of computational fluid dynamics [25]. Thus, ML-based CT-FFR could potentially be used as a guide to cCTA, or could even serve as a replacement of morphological cCTA analysis without the restrictions of time and costs related to off-site solutions.
In this study, we analyzed the ability of on-site ML-based CT-FFR to correctly categorize cCTA studies without morphological signs of obstructive CAD acquired during pre-TAVI evaluation. The secondary objective was to correlate recategorization to image quality measures and CAC.

2. Materials and Methods

2.1. Study Design

The study design has previously been described in detail in [8]. Over a period of 7 months, 517 consecutive patients referred for CT prior to TAVI were screened. Overall, 388 patients had received the identical CT protocol and an ICA suitable for quantitative coronary analysis (QCA) within 3 months. Of these, 116 patients (116/388) had no morphological signs of obstructive CAD on cCTA (no stenosis of ≥50% diameter) and were included (Figure 1).
The study was conducted in compliance with the Declaration of Helsinki (Medical Association 2013). The local ethics committee approved the study and written informed consent was waived (reference number: 435/18-ek).

2.2. CT Acquisition

The scan protocol has previously been described in a more detailed manner in [8]. All patients were examined with the same scanner (Somatom Definition Flash; Siemens, Erlangen, Germany) and scan protocol. The scan protocol consisted of a nonenhanced prospectively ECG-triggered scan of the heart, and a retrospectively ECG-gated helical scan of the heart, immediately followed by high-pitch scan of the torso utilizing a single bolus of 70 mL contrast medium. No nitrates or beta blockers or other forms of patient-specific medication or adjustment were applied.

2.3. cCTA, ICA and QCA

cCTA had previously been evaluated morphologically for the presence of obstructive CAD (stenosis ≥50% diameter), separately for each segment according to the 18-segment model [8,26]. Results per vessel and patient were formed by considering the worst comprising segment, respectively. The standard of reference was ICA with QCA using the same threshold of ≥50% diameter.

2.4. Image Quality of cCTA and CAC

Image quality was assessed quantitatively and qualitatively as previously described [8,18]. Quantitatively, image quality was described as contrast opacification in the aortic sinus in Hounsfield units (HU) and as contrast to noise ratio (CNR) = H U   a t   a o r t i c   s i n u s H U   a t   i n t e r v e n t r i c u l a r   s e p t u m n o i s e   o f   s u b c u t a n e o u s   a d i p o s e   t i s s u e .
Qualitatively, contrast opacification, noise and artefacts were assessed and image quality was scored into one of the following four categories by considering the worst comprising component:
  • 0 = nondiagnostic (excluded from this analysis, as CAD could not be excluded)
  • 1 = diagnostic
  • 2 = good
  • 3 = excellent
CAC was determined using standard technique, separately for each of the four main coronary vessels [27]. Patients’ CACs was formed by summation.

2.5. CT-FFR

cCTA examinations without morphological signs of obstructive CAD (no stenosis ≥50% diameter) were re-evaluated with ML-based CT-FFR (cFFR version 3.2.0; Siemens, Erlangen, Germany; not commercially available) [24]. For this, epicardial coronary arteries with a minimum diameter of 1.5 mm were segmented and ML-based CT-FFR was computed. The time required for segmentation in this patient cohort was approximately 10 min on average and ranged from 5 to 30 min, depending on CNR and plaque burden. The actual computation of ML-based CT-FFR values was rapid (<5 s). CT-FFR measurements were taken for each segment of the 18-segment model at the junction of the middle and distal third within the respective segment [26]. Vessel and patient readings were formed by considering the respective minimum value. CT-FFR values ≤0.80 were considered to be indicative of hemodynamically significant CAD [28].

2.6. Statistical Analysis

Categorical variables are given as count and percentage; ordinal data is given as median and interquartile range (IQR). Continuous variables are expressed as mean and standard deviation (SD) when symmetrically distributed or as median and IQR for skewed distributions. Group comparisons were performed using independent two-sample t-tests for continuous symmetrically distributed variables and Mann–Whitney U tests for continuous skewed or ordinal data. For correlation analyses between recategorization status and potential disturbing variables, e.g., CAC or reduced quantitative and qualitative image quality, correlation coefficients and corresponding confidence intervals (CIs) were calculated. For this, rank-biserial correlation (between binary and continuous skewed or ordinal data) or point-biserial correlation (between binary and continuous symmetrically distributed variables) were applied. Correlation coefficients are denoted as r r b and r p b , respectively. p-values correspond to the null hypothesis of the respective coefficient being zero. All tests were performed at a significance level of 5%. CIs are reported at a confidence level of 0.95.
Data curation and computation of inferential statistics were performed with spreadsheets (Microsoft Excel version 2010, Microsoft Corporation, Redmond, WA, USA). For further statistical analyses, R (v4.1.2, R Foundation for Statistical Computing, Vienna, Austria) was used.

3. Results

3.1. ML-Based CT-FFR

ML-based CT-FFR was successfully performed in 109 of the 116 (94.0%) cCTA exams without morphological signs of obstructive CAD. In 7 patients, ML-based CT-FFR was not feasible. Reasons for this were image quality hindering the seamless segmentation of the coronary tree (stitching artefacts or no single reconstruction with all segments depicted diagnostically at the same time; n = 3) or coronary anatomy, namely coronary anomalies or atypically dominant branches, outside of the boundaries the algorithm had been trained for [24], rendering errors during computation of CT-FFR (n = 4) (Figure 1).
When applied to all studies, ML-based CT-FFR recategorized 76 patients, 126 vessels and 186 segments from true negative (TN) to false positive (FP), respectively. Two patients initially categorized as false negative (FN) by cCTA were recategorized as true positive (TP) by CT-FFR. As the two vessels initially categorized as FN by cCTA were not recategorized by CT-FFR on vessel level, recategorization from FN to TP on patient level accrued because of a FP rating elsewhere in the coronary tree. As a consequence of the relatively high rate of recategorization from TN to FP, specificity and accuracy decreased by 71.0 and 67.9 percentage points on patient level, respectively. Further detail regarding the impact of CT-FFR on the diagnostic performance, including accuracy on patient, vessel and segment level, is shown in Table 1.
The rate of recategorization from TN with cCTA to FN with CT-FFR was low proximally in the vessels, with no or few recategorizations accruing in segments 1, 5, 6 and 11, and high in more distal segments. The number and rate of recategorizations for each segment and vessel as well as per patient are shown in Table 2.

3.2. Analysis According to Image Quality and CAC

CAC in the left anterior descending coronary artery (LAD) was significantly higher in patients recategorized as FP (CACLAD: 42.6 (183.8); 118.0 (315.1); p = 0.04 ). No further significant group differences in image quality parameters or CAC were noted between patients or vessels categorized as TN or FP ( p 0.10 ) (Table 3).
Correlation between quantitative image quality parameters and recategorization from TN to FP was not significant (contrast opacification: r p b = 0.07 , p = 0.48 ; CNR: r p b = 0.007 , p = 0.95 ). No dependence of recategorization and image quality score was found (image quality score 1: FP: 15, TN: 3; score 2: FP: 34, TN: 18; score 3: FP: 27, TN: 10; r r b = 0.03 ; p = 0.73 ). For further detail see Table 3 and Figure 2.
A weak negative correlation of CAC and recategorization to FP was found in the LAD ( r r b = 0.20 ; p = 0.03 ). No further significant correlation of CAC and recategorization could be observed on patient or vessel level (patient: r r b = 0.16 ; right coronary artery: r r b = 0.08 ; circumflex artery: r r b = 0.01 ; p 0.10 ). Further details are shown in Table 3 and Figure 3.

4. Discussion

cCTA is a highly useful test for the detection and exclusion of obstructive CAD, characterized by high sensitivity and high negative predictive value. However, its specificity and positive predictive value are somewhat limited, and its diagnostic accuracy decreases with increasing plaque burden as frequently encountered in elderly patients [29], including patients prior to TAVI. Though CT-FFR has been shown to increase specificity and diagnostic accuracy also in this patient group when applied for specific lesions [18,19], interpreting cCTA and deciding between obstructive and non-obstructive CAD in patients with higher plaque burden may be challenging and requires experience. Therefore, it would be most convenient if CT-FFR could not only guide the semiquantitative interpretation of cCTA [20] but rather render a discrete value indicative of hemodynamically relevant CAD, thus making the more subjective morphological interpretation unnecessary. With this approach, CT-FFR could serve as a screening test and potentially facilitate decision making, particularly for less experienced readers or in more challenging cCTA examinations, e.g., in the group of patients prior to TAVI. To best illustrate the effect of an approach omitting the morphological evaluation, only exams previously acquitted of obstructive CAD were included in this analysis.
ML-based CT-FFR now enables such a workflow without the time or cost restraints applicable to earlier approaches [21,22,23] with the computation of CT-FFR on-site. However, our results demonstrate a false positive rate of 70% for CT-FFR in cCTA studies without morphological signs of obstructive CAD (no stenosis ≥50%). As a consequence, diagnostic accuracy was substantially degraded. Furthermore, the two patients formerly categorized as false negative with cCTA were only coincidentally recategorized as true positive on patient level because of false positive CT-FFR values elsewhere in the coronary tree (Table 1). Therefore, our results clearly discourage the unselective use of CT-FFR.
The vast majority of false positive CT-FFR readings in regard to hemodynamic significant CAD were observed in more distal segments (Table 2, Figure 4). While it is generally recommended to consider CT-FFR values 1–2 cm distal to the lesion [28], this recommendation cannot be followed in patients with diffuse CAD or no discernable lesion whatsoever. Two previous studies have compared minimal CT-FFR measurements and measurements taken 2 cm distal to the lesion of interest. CT-FFR readings taken 2 cm distal to the lesion reduced the false positive rate by 44% and 54% with the same threshold, respectively [30,31]. While increased coronary artery resistance may be a product of diffuse atherosclerosis in the absence of obstructive CAD [32], we do not believe this to be the explanation for the majority of abnormal CT-FFR readings in our study cohort. Perhaps an imbalance between epicardial arterial volume and myocardial mass in patients with severe aortic stenosis caused by left ventricular hypertrophy may be a better explanation for the frequently low CT-FFR values in the distal coronary artery segments in our patient cohort [33,34].
The lack of patient preparation with nitroglycerine and beta blockers may degrade image quality and diagnostic accuracy of cCTA and CT-FFR [35,36]. However, we found no association between recategorization to false positive ratings and quantitatively or qualitatively assessed image quality in our study (Table 3 and Figure 2).
Similarly, CAC is well known to degrade diagnostic performance of both cCTA and CT-FFR [17,37,38]. Nevertheless, we only found a weak correlation between CAC and recategorization to FP for the LAD, prompted by very high CAC (CAC >400) (Table 3 and Figure 3). No correlation of CAC and recategorization was found for the remaining vessels or analysis on patient level (Table 3, Figure 3 and Figure 5).
The lack of relevant correlation between image quality measures and CAC may initially seem surprising. However, as this is an analysis of the performance of CT-FFR carried out on cCTA studies without morphological signs of obstructive CAD only, cCTA exams with impaired luminal delineation had already been excluded beforehand. Therefore, it is likely that the portrayal of the coronary artery lumen itself, rather than image quality or CAC, influence the values given by CT-FFR. It is thus likely that other factors are responsible for the false recategorization of studies without discrete stenosis in this patient cohort. As previously discussed, these factors may be diffuse atherosclerosis [32], or may potentially signify pathophysiology in patients with severe aortic stenosis, such as as an imbalance between epicardial arterial volume and myocardial mass [33,34].
All the same, if not applied lesion-specifically, CT-FFR may recategorize the majority of patients without morphological signs of obstructive CAD as false positive. Recategorization occurred much more frequently towards the distal portion of the coronary tree and was virtually independent of image quality measures or CAC. Thus, CT-FFR is not a suitable screening tool for CAD in the patient cohort prior to TAVI in this setting.
Physiologically, pressure gradients continuously decrease along any vessel, and, therefore, a discrete cut-off is perhaps not the best measure [39]. Potentially, other modes of measurement could prove to be better markers, for example, the relative change along the vessel per distance or between segments (delta) [40]. This would be interesting to explore also in this patient group.

Limitations

This was a retrospective single-center study with an unusual selection of exams, namely cCTA studies of TAVI candidates without morphological signs of obstructive CAD. Thus, caution should be practiced when applying the results to different patient cohorts or types of cCTA exams.
It is well known that the lack of the administration of nitrates or beta blockers may degrade image quality and consequently diagnostic accuracy of both cCTA and CT-FFR [35,36]. However, as only exams without morphological signs of obstructive CAD were included, no exams with insufficient image quality for the delineation of the coronary lumina were included. This selection may explain the virtual lack of correlation of recategorization to image quality measures and CAC.
The standard of reference was ICA with QCA with a conservative threshold of ≥50% diameter stenosis. Despite being a very sensitive cut-off that will frequently not prompt therapy, it is morphological and it remains unclear whether or not the values obtained with CT-FFR are truly false low/positive at the location of measurement. Although very interesting, invasive functional measurements in patients with severe aortic stenosis and consequently altered hemodynamics remain controversial [41,42].

5. Conclusions

ML-based CT-FFR should carefully be used if utilized as a screening tool for CAD, e.g., for less experienced cCTA readers. Because, if unselectively applied, CT-FFR may vastly increase the number of false positive ratings of CAD compared to morphological scoring in patients before TAVI in the absence of obstructive lesions, particularly in distal segments. Recategorization to false positive was virtually independent of image quality or coronary artery calcium score. It is unclear whether or not the pathologically reduced CT-FFR represent true pressure ratios and potentially signifies pathophysiology in patients with severe aortic stenosis.

Author Contributions

Conceptualization, R.F.G., P.S., M.H. and M.G.; formal analysis, M.H.; methodology, R.F.G., P.S., M.A.-W. and M.G.; project administration, M.A.-W. and M.G.; supervision, M.G.; data curation, R.F.G., A.S. and K.P.; investigation, all authors but A.S., K.P. and M.H.; visualization, R.F.G., P.S., L.H. and K.R.; Software, C.P.; Recourses, M.A.-W. and M.G.; writing—original draft, R.F.G., P.S. and M.H.; writing—review and editing, all authors. All authors have contributed substantially to this work. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Informed Consent Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the University of Leipzig (435/18-ek, 15.08.2019).

Data Availability Statement

The datasets generated and/or analyzed during the current study are not publicly available due to German Data Protection laws but are available from the corresponding author on reasonable request after approval of the local ethics committee and data safety board.

Acknowledgments

The authors thank Siemens Healthcare for providing the prototype software. We acknowledge the position of Robin F. Gohmann to have been equally funded by Leipzig University and Leipzig Heart Center. We acknowledge support from Leipzig University for Open Access Publishing. The authors thank Werner Daßler for his dependable, kind and thorough support in language editing.

Conflicts of Interest

C. Panknin is an employee of Siemens Healthcare. None of the authors have conflicts of interest to be stated. No grants or other forms of financial support were utilized for this work.

References

  1. Baumgartner, H.; Falk, V.; Bax, J.J.; de Bonis, M.; Hamm, C.; Holm, P.J.; Iung, B.; Lancellotti, P.; Lansac, E.; Rodriguez Muñoz, D.; et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2017, 38, 2739–2791. [Google Scholar] [CrossRef] [PubMed]
  2. Nishimura, R.A.; Otto, C.M.; Bonow, R.O.; Carabello, B.A.; Erwin, J.P.; Fleisher, L.A.; Jneid, H.; Mack, M.J.; McLeod, C.J.; O’Gara, P.T.; et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. J. Am. Coll. Cardiol. 2017, 70, 252–289. [Google Scholar] [CrossRef]
  3. Blanke, P.; Weir-McCall, J.R.; Achenbach, S.; Delgado, V.; Hausleiter, J.; Jilaihawi, H.; Marwan, M.; Nørgaard, B.L.; Piazza, N.; Schoenhagen, P.; et al. Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR): An Expert Consensus Document of the Society of Cardiovascular Computed Tomography. JACC Cardiovasc. Imaging 2019, 12, 1–24. [Google Scholar] [CrossRef] [PubMed]
  4. Francone, M.; Budde, R.P.J.; Bremerich, J.; Dacher, J.N.; Loewe, C.; Wolf, F.; Natale, L.; Pontone, G.; Redheuil, A.; Vliegenthart, R.; et al. CT and MR imaging prior to transcatheter aortic valve implantation: Standardisation of scanning protocols, measurements and reporting—A consensus document by the European Society of Cardiovascular Radiology (ESCR). Eur. Radiol. 2020, 30, 2627–2650. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Nishimura, R.A.; Otto, C.M.; Bonow, R.O.; Carabello, B.A.; Erwin, J.P.; Guyton, R.A.; O’Gara, P.T.; Ruiz, C.E.; Skubas, N.J.; Sorajja, P.; et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014, 63, 2438–2488. [Google Scholar] [CrossRef] [Green Version]
  6. Andreini, D.; Pontone, G.; Mushtaq, S.; Bartorelli, A.L.; Ballerini, G.; Bertella, E.; Segurini, C.; Conte, E.; Annoni, A.; Baggiano, A.; et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement. Am. Heart J. 2014, 168, 332–339. [Google Scholar] [CrossRef]
  7. Annoni, A.D.; Andreini, D.; Pontone, G.; Mancini, M.E.; Formenti, A.; Mushtaq, S.; Baggiano, A.; Conte, E.; Guglielmo, M.; Muscogiuri, G.; et al. CT angiography prior to TAVI procedure using third-generation scanner with wide volume coverage: Feasibility, renal safety and diagnostic accuracy for coronary tree. Br. J. Radiol. 2018, 91, 20180196. [Google Scholar] [CrossRef]
  8. Gohmann, R.F.; Lauten, P.; Seitz, P.; Krieghoff, C.; Lücke, C.; Gottschling, S.; Mende, M.; Weiß, S.; Wilde, J.; Kiefer, P.; et al. Combined Coronary CT-Angiography and TAVI-Planning: A Contrast-Neutral Routine Approach for Ruling-out Significant Coronary Artery Disease. J. Clin. Med. 2020, 9, 1623. [Google Scholar] [CrossRef]
  9. Hamdan, A.; Wellnhofer, E.; Konen, E.; Kelle, S.; Goitein, O.; Andrada, B.; Raanani, E.; Segev, A.; Barbash, I.; Klempfner, R.; et al. Coronary CT angiography for the detection of coronary artery stenosis in patients referred for transcatheter aortic valve replacement. J. Cardiovasc. Comput. Tomogr. 2015, 9, 31–41. [Google Scholar] [CrossRef] [PubMed]
  10. Harris, B.S.; de Cecco, C.N.; Schoepf, U.J.; Steinberg, D.H.; Bayer, R.R.; Krazinski, A.W.; Dyer, K.T.; Sandhu, M.K.; Zile, M.R.; Meinel, F.G. Dual-source CT imaging to plan transcatheter aortic valve replacement: Accuracy for diagnosis of obstructive coronary artery disease. Radiology 2015, 275, 80–88. [Google Scholar] [CrossRef]
  11. Matsumoto, S.; Yamada, Y.; Hashimoto, M.; Okamura, T.; Yamada, M.; Yashima, F.; Hayashida, K.; Fukuda, K.; Jinzaki, M. CT imaging before transcatheter aortic valve implantation (TAVI) using variable helical pitch scanning and its diagnostic performance for coronary artery disease. Eur. Radiol. 2017, 27, 1963–1970. [Google Scholar] [CrossRef] [PubMed]
  12. Opolski, M.P.; Kim, W.-K.; Liebetrau, C.; Walther, C.; Blumenstein, J.; Gaede, L.; Kempfert, J.; van Linden, A.; Walther, T.; Hamm, C.W.; et al. Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation. Clin. Res. Cardiol. 2015, 104, 471–480. [Google Scholar] [CrossRef]
  13. Pontone, G.; Andreini, D.; Bartorelli, A.L.; Annoni, A.; Mushtaq, S.; Bertella, E.; Formenti, A.; Cortinovis, S.; Alamanni, F.; Fusari, M.; et al. Feasibility and accuracy of a comprehensive multidetector computed tomography acquisition for patients referred for balloon-expandable transcatheter aortic valve implantation. Am. Heart J. 2011, 161, 1106–1113. [Google Scholar] [CrossRef] [PubMed]
  14. Rossi, A.; de Cecco, C.N.; Kennon, S.R.O.; Zou, L.; Meinel, F.G.; Toscano, W.; Segreto, S.; Achenbach, S.; Hausleiter, J.; Schoepf, U.J.; et al. CT angiography to evaluate coronary artery disease and revascularization requirement before trans-catheter aortic valve replacement. J. Cardiovasc. Comput. Tomogr. 2017, 11, 338–346. [Google Scholar] [CrossRef] [PubMed]
  15. Strong, C.; Ferreira, A.; Teles, R.C.; Mendes, G.; Abecasis, J.; Cardoso, G.; Guerreiro, S.; Freitas, P.; Santos, A.C.; Saraiva, C.; et al. Diagnostic accuracy of computed tomography angiography for the exclusion of coronary artery disease in candidates for transcatheter aortic valve implantation. Sci. Rep. 2019, 9, 19942. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Grover, F.L.; Vemulapalli, S.; Carroll, J.D.; Edwards, F.H.; Mack, M.J.; Thourani, V.H.; Brindis, R.G.; Shahian, D.M.; Ruiz, C.E.; Jacobs, J.P.; et al. 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J. Am. Coll. Cardiol. 2017, 69, 1215–1230. [Google Scholar] [CrossRef] [PubMed]
  17. Abdulla, J.; Pedersen, K.S.; Budoff, M.; Kofoed, K.F. Influence of coronary calcification on the diagnostic accuracy of 64-slice computed tomography coronary angiography: A systematic review and meta-analysis. Int. J. Cardiovasc. Imaging 2012, 28, 943–953. [Google Scholar] [CrossRef]
  18. Gohmann, R.F.; Pawelka, K.; Seitz, P.; Majunke, N.; Heiser, L.; Renatus, K.; Desch, S.; Lauten, P.; Holzhey, D.; Noack, T.; et al. Combined Coronary CT-Angiography and TAVR Planning for Ruling Out Significant Coronary Artery Disease: Added Value of Machine-Learning-Based CT-FFR. JACC Cardiovasc. Imaging 2021. Epub ahead of print. [Google Scholar] [CrossRef] [PubMed]
  19. Michail, M.; Ihdayhid, A.-R.; Comella, A.; Thakur, U.; Cameron, J.D.; McCormick, L.M.; Gooley, R.P.; Nicholls, S.J.; Mathur, A.; Hughes, A.D.; et al. Feasibility and Validity of Computed Tomography-Derived Fractional Flow Reserve in Patients With Severe Aortic Stenosis: The CAST-FFR Study. Circ. Cardiovasc. Interv. 2021, 14, e009586. [Google Scholar] [CrossRef] [PubMed]
  20. Artzner, C.; Daubert, M.; Ehieli, W.; Kong, D.; Mammarappallil, J.; Nikolaou, K.; Boll, D.T.; Koweek, L. Impact of computed tomography (CT)-derived fractional flow reserve on reader confidence for interpretation of coronary CT angiography. Eur. J. Radiol. 2018, 108, 242–248. [Google Scholar] [CrossRef] [PubMed]
  21. Karády, J.; Mayrhofer, T.; Ivanov, A.; Foldyna, B.; Lu, M.T.; Ferencik, M.; Pursnani, A.; Salerno, M.; Udelson, J.E.; Mark, D.B.; et al. Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain. JAMA Netw. Open 2020, 3, e2028312. [Google Scholar] [CrossRef]
  22. O’Riordan, M. No Cost Savings with Routine FFRCT for New-Onset Chest Pain: FORECAST: FFRCT Did Reduce the Use of Invasive Angiography, but the Savings Weren’t Enough to Offset the Up-Front Costs of Testing. Available online: https://www.tctmd.com/news/no-cost-savings-routine-ffrct-new-onset-chest-pain-forecast (accessed on 8 January 2022).
  23. Graby, J.; Metters, R.; Kandan, S.R.; McKenzie, D.; Lowe, R.; Carson, K.; Hudson, B.J.; Rodrigues, J.C.L. Real-world clinical and cost analysis of CT coronary angiography and CT coronary angiography-derived fractional flow reserve (FFRCT)-guided care in the National Health Service. Clin. Radiol. 2021, 76, 862.e19. [Google Scholar] [CrossRef]
  24. Itu, L.; Rapaka, S.; Passerini, T.; Georgescu, B.; Schwemmer, C.; Schoebinger, M.; Flohr, T.; Sharma, P.; Comaniciu, D. A machine-learning approach for computation of fractional flow reserve from coronary computed tomography. J. Appl. Physiol. 2016, 121, 42–52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Coenen, A.; Kim, Y.-H.; Kruk, M.; Tesche, C.; de Geer, J.; Kurata, A.; Lubbers, M.L.; Daemen, J.; Itu, L.; Rapaka, S.; et al. Diagnostic Accuracy of a Machine-Learning Approach to Coronary Computed Tomographic Angiography-Based Fractional Flow Reserve: Result From the MACHINE Consortium. Circ. Cardiovasc. Imaging 2018, 11, e007217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Leipsic, J.; Abbara, S.; Achenbach, S.; Cury, R.; Earls, J.P.; Mancini, G.J.; Nieman, K.; Pontone, G.; Raff, G.L. SCCT guidelines for the interpretation and reporting of coronary CT angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J. Cardiovasc. Comput. Tomogr. 2014, 8, 342–358. [Google Scholar] [CrossRef] [PubMed]
  27. Agatston, A.S.; Janowitz, W.R.; Hildner, F.J.; Zusmer, N.R.; Viamonte, M.; Detrano, R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 1990, 15, 827–832. [Google Scholar] [CrossRef] [Green Version]
  28. Nørgaard, B.L.; Fairbairn, T.A.; Safian, R.D.; Rabbat, M.G.; Ko, B.; Jensen, J.M.; Nieman, K.; Chinnaiyan, K.M.; Sand, N.P.; Matsuo, H.; et al. Coronary CT Angiography-derived Fractional Flow Reserve Testing in Patients with Stable Coronary Artery Disease: Recommendations on Interpretation and Reporting. Radiol. Cardiothorac. Imaging 2019, 1, e190050. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Knuuti, J.; Wijns, W.; Saraste, A.; Capodanno, D.; Barbato, E.; Funck-Brentano, C.; Prescott, E.; Storey, R.F.; Deaton, C.; Cuisset, T.; et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2020, 41, 407–477. [Google Scholar] [CrossRef] [PubMed]
  30. Kueh, S.H.; Mooney, J.; Ohana, M.; Kim, U.; Blanke, P.; Grover, R.; Sellers, S.; Ellis, J.; Murphy, D.; Hague, C.; et al. Fractional flow reserve derived from coronary computed tomography angiography reclassification rate using value distal to lesion compared to lowest value. J. Cardiovasc. Comput. Tomogr. 2017, 11, 462–467. [Google Scholar] [CrossRef] [PubMed]
  31. Nozaki, Y.O.; Fujimoto, S.; Aoshima, C.; Kamo, Y.; Kawaguchi, Y.O.; Takamura, K.; Kudo, A.; Takahashi, D.; Hiki, M.; Kato, Y.; et al. Comparison of diagnostic performance in on-site based CT-derived fractional flow reserve measurements. Int. J. Cardiol. Heart Vasc. 2021, 35, 100815. [Google Scholar] [CrossRef] [PubMed]
  32. de Bruyne, B.; Hersbach, F.; Pijls, N.H.; Bartunek, J.; Bech, J.W.; Heyndrickx, G.R.; Gould, K.L.; Wijns, W. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “Normal” coronary angiography. Circulation 2001, 104, 2401–2406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Coenen, A.; Lubbers, M.M.; Kurata, A.; Kono, A.; Dedic, A.; Chelu, R.G.; Dijkshoorn, M.L.; Gijsen, F.J.; Ouhlous, M.; van Geuns, R.-J.M.; et al. Fractional flow reserve computed from noninvasive CT angiography data: Diagnostic performance of an on-site clinician-operated computational fluid dynamics algorithm. Radiology 2015, 274, 674–683. [Google Scholar] [CrossRef]
  34. Choy, J.S.; Kassab, G.S. Scaling of myocardial mass to flow and morphometry of coronary arteries. J. Appl. Physiol. 2008, 104, 1281–1286. [Google Scholar] [CrossRef] [Green Version]
  35. Xu, P.P.; Li, J.H.; Zhou, F.; Jiang, M.D.; Zhou, C.S.; Lu, M.J.; Tang, C.X.; Zhang, X.L.; Yang, L.; Zhang, Y.X.; et al. The influence of image quality on diagnostic performance of a machine learning-based fractional flow reserve derived from coronary CT angiography. Eur. Radiol. 2020, 30, 2525–2534. [Google Scholar] [CrossRef] [PubMed]
  36. Leipsic, J.; Yang, T.-H.; Thompson, A.; Koo, B.-K.; Mancini, G.B.J.; Taylor, C.; Budoff, M.J.; Park, H.-B.; Berman, D.S.; Min, J.K. CT angiography (CTA) and diagnostic performance of noninvasive fractional flow reserve: Results from the Determination of Fractional Flow Reserve by Anatomic CTA (DeFACTO) study. AJR Am. J. Roentgenol. 2014, 202, 989–994. [Google Scholar] [CrossRef] [PubMed]
  37. Kawaguchi, Y.O.; Fujimoto, S.; Kumamaru, K.K.; Kato, E.; Dohi, T.; Takamura, K.; Aoshima, C.; Kamo, Y.; Kato, Y.; Hiki, M.; et al. The predictive factors affecting false positive in on-site operated CT-fractional flow reserve based on fluid and structural interaction. Int. J. Cardiol. Heart Vasc. 2019, 23, 100372. [Google Scholar] [CrossRef] [PubMed]
  38. Tesche, C.; Otani, K.; de Cecco, C.N.; Coenen, A.; de Geer, J.; Kruk, M.; Kim, Y.-H.; Albrecht, M.H.; Baumann, S.; Renker, M.; et al. Influence of Coronary Calcium on Diagnostic Performance of Machine Learning CT-FFR: Results From MACHINE Registry. JACC Cardiovasc. Imaging 2020, 13, 760–770. [Google Scholar] [CrossRef] [PubMed]
  39. Cami, E.; Tagami, T.; Raff, G.; Fonte, T.A.; Renard, B.; Gallagher, M.J.; Chinnaiyan, K.; Bilolikar, A.; Fan, A.; Hafeez, A.; et al. Assessment of lesion-specific ischemia using fractional flow reserve (FFR) profiles derived from coronary computed tomography angiography (FFRCT) and invasive pressure measurements (FFRINV): Importance of the site of measurement and implications for patient referral for invasive coronary angiography and percutaneous coronary intervention. J. Cardiovasc. Comput. Tomogr. 2018, 12, 480–492. [Google Scholar] [CrossRef]
  40. Takagi, H.; Ishikawa, Y.; Orii, M.; Ota, H.; Niiyama, M.; Tanaka, R.; Morino, Y.; Yoshioka, K. Optimized interpretation of fractional flow reserve derived from computed tomography: Comparison of three interpretation methods. J. Cardiovasc. Comput. Tomogr. 2019, 13, 134–141. [Google Scholar] [CrossRef]
  41. Ahmad, Y.; Götberg, M.; Cook, C.; Howard, J.P.; Malik, I.; Mikhail, G.; Frame, A.; Petraco, R.; Rajkumar, C.; Demir, O.; et al. Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: Implications for Clinical Indices of Coronary Stenosis Severity. JACC Cardiovasc. Interv. 2018, 11, 2019–2031. [Google Scholar] [CrossRef]
  42. Scarsini, R.; Pesarini, G.; Zivelonghi, C.; Piccoli, A.; Ferrero, V.; Lunardi, M.; Gottin, L.; Zanetti, C.; Faggian, G.; Ribichini, F. Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2018, 13, 1512–1519. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Flowchart of the study population according to diagnostics received. CAD—no obstructive CAD on cCTA; CAD+—obstructive CAD (stenosis ≥50%) on cCTA; cCTA—coronary CT-angiography; CT-FFR—CT-derived fractional flow reserve; cCTA—coronary CT-angiography; ICA—invasive coronary angiography; QCA—quantitative coronary analysis.
Figure 1. Flowchart of the study population according to diagnostics received. CAD—no obstructive CAD on cCTA; CAD+—obstructive CAD (stenosis ≥50%) on cCTA; cCTA—coronary CT-angiography; CT-FFR—CT-derived fractional flow reserve; cCTA—coronary CT-angiography; ICA—invasive coronary angiography; QCA—quantitative coronary analysis.
Jcm 11 01331 g001
Figure 2. Dot-plot of cCTA image quality parameters and categorization according to ML-based CT-FFR of patients without morphological signs of obstructive CAD on cCTA. Recategorization of patients as false positive was independent of image quality, regardless of the concrete measure and accrued with comparable frequency in exams with diagnostic, good and exceptional image quality. The standard of reference was ICA with QCA. Thresholds were ≥50% diameter for cCTA and QCA and ≤0.80 for CT-FFR. Note—the two patients and vessels falsely categorized as negative with cCTA were excluded from this plot. cCTA—coronary CT-angiography; FN—false negative; FP—false positive; HU—Hounsfield units; ICA—invasive coronary angiography; ML—machine learning; QCA—quantitative coronary analysis.
Figure 2. Dot-plot of cCTA image quality parameters and categorization according to ML-based CT-FFR of patients without morphological signs of obstructive CAD on cCTA. Recategorization of patients as false positive was independent of image quality, regardless of the concrete measure and accrued with comparable frequency in exams with diagnostic, good and exceptional image quality. The standard of reference was ICA with QCA. Thresholds were ≥50% diameter for cCTA and QCA and ≤0.80 for CT-FFR. Note—the two patients and vessels falsely categorized as negative with cCTA were excluded from this plot. cCTA—coronary CT-angiography; FN—false negative; FP—false positive; HU—Hounsfield units; ICA—invasive coronary angiography; ML—machine learning; QCA—quantitative coronary analysis.
Jcm 11 01331 g002
Figure 3. Dot-plot of patients’ and vessels’ CAC and categorization according to ML-based CT-FFR of cCTA studies without morphological signs of obstructive CAD on cCTA. Recategorization of patients and vessels was independent of CAC, occurring with roughly equal frequency with various extents of CAC. The standard of reference was ICA with QCA. Thresholds were ≥50% diameter for cCTA and QCA and ≤0.80 for CT-FFR. Note—the two patients and vessels falsely categorized as negative with cCTA were excluded from this plot. CAC was not available for all patients. CAC—coronary artery calcium score; cCTA—coronary CT-angiography; CX—circumflex artery, FN—false negative; FP—false positive; ICA—invasive coronary angiography; LAD—left anterior descending artery; ML—machine learning; RCA—right coronary artery; QCA—quantitative coronary analysis.
Figure 3. Dot-plot of patients’ and vessels’ CAC and categorization according to ML-based CT-FFR of cCTA studies without morphological signs of obstructive CAD on cCTA. Recategorization of patients and vessels was independent of CAC, occurring with roughly equal frequency with various extents of CAC. The standard of reference was ICA with QCA. Thresholds were ≥50% diameter for cCTA and QCA and ≤0.80 for CT-FFR. Note—the two patients and vessels falsely categorized as negative with cCTA were excluded from this plot. CAC was not available for all patients. CAC—coronary artery calcium score; cCTA—coronary CT-angiography; CX—circumflex artery, FN—false negative; FP—false positive; ICA—invasive coronary angiography; LAD—left anterior descending artery; ML—machine learning; RCA—right coronary artery; QCA—quantitative coronary analysis.
Jcm 11 01331 g003
Figure 4. CT-FFR rendering values indicating hemodynamic significance with no apparent luminal narrowing on cCTA nor ICA: Mildly calcified left coronary artery (total CAC = 72 AU) with trifurcation into left anterior descending (LAD), left circumflex (LCX) and intermediate artery. CT-FFR values drop below 0.80 between the middle and distal segment (segment 6/7) (asterisk) (a). There is no discernable luminal obstruction on cCTA depicted as curved multiplanar reformation (b) nor on the corresponding projection of ICA (c). CAC—coronary artery calcium score; cCTA—coronary CT-angiography; CT-FFR—CT-derived fractional flow reserve; ICA—invasive coronary angiography.
Figure 4. CT-FFR rendering values indicating hemodynamic significance with no apparent luminal narrowing on cCTA nor ICA: Mildly calcified left coronary artery (total CAC = 72 AU) with trifurcation into left anterior descending (LAD), left circumflex (LCX) and intermediate artery. CT-FFR values drop below 0.80 between the middle and distal segment (segment 6/7) (asterisk) (a). There is no discernable luminal obstruction on cCTA depicted as curved multiplanar reformation (b) nor on the corresponding projection of ICA (c). CAC—coronary artery calcium score; cCTA—coronary CT-angiography; CT-FFR—CT-derived fractional flow reserve; ICA—invasive coronary angiography.
Jcm 11 01331 g004
Figure 5. CT-FFR confirming negative cCTA: Heavily calcified left coronary artery (total CAC = 1834 AU) with trifurcation into left anterior descending (LAD), left circumflex (LCX) and intermediate artery without luminal obstruction depicted on cCTA as curved multiplanar reformation (a) and volume-rendered technique (b). The corresponding projection of invasive coronary angiography shows no stenosis (c). CT-FFR shows normal values well above 0.80 up to the distal vessels with a physiological drop-off of values only in the most distal runoffs (d). CAC—coronary artery calcium score; cCTA—coronary CT-angiography; CT-FFR—CT-derived fractional flow reserve. Adapted with permission from Gohmann et al. [8].
Figure 5. CT-FFR confirming negative cCTA: Heavily calcified left coronary artery (total CAC = 1834 AU) with trifurcation into left anterior descending (LAD), left circumflex (LCX) and intermediate artery without luminal obstruction depicted on cCTA as curved multiplanar reformation (a) and volume-rendered technique (b). The corresponding projection of invasive coronary angiography shows no stenosis (c). CT-FFR shows normal values well above 0.80 up to the distal vessels with a physiological drop-off of values only in the most distal runoffs (d). CAC—coronary artery calcium score; cCTA—coronary CT-angiography; CT-FFR—CT-derived fractional flow reserve. Adapted with permission from Gohmann et al. [8].
Jcm 11 01331 g005
Table 1. Comparison of cCTA and ML-based CT-FFR of patients without morphological signs of obstructive CAD.
Table 1. Comparison of cCTA and ML-based CT-FFR of patients without morphological signs of obstructive CAD.
nTPTNFPFNSen.Spe.PPVNPVAcc.
Patients cCTA1090107020.0%100.0% 98.2%98.2%
Patients CT-FFR231760100.0%29.0%2.6%100.0%30.3%
Difference Δ: patient level2−7676−2+100.0%−71.0% +1.8%−67.9%
Vessels cCTA4360434020.0%100.0% 99.5%99.5%
Vessels CT-FFR030812620.0%71.0%0.0%99.4%70.6%
Difference Δ: vessel level0−12612600.0%−29.0% −0.2%−28.9%
Segments cCTA145601454020.0%100.0% 99.9%99.9%
Segments CT-FFR0126818620.0%87.2%0.0%99.8%87.1%
Difference Δ: segment level0−18618600.0%−12.8% 0.0%−12.8%
Results of coronary artery analysis with cCTA of a previous study [8] and analysis of ML-based CT-FFR against ICA/QCA on patient, vessel, and segment level. Thresholds for obstructive CAD were ≥50% diameter for cCTA and QCA and for hemodynamically significant CAD on CT-FFR ≤0.80, respectively. FN and TP results are ramifications from initial misclassification by cCTA. Acc.—accuracy; CAD—negative for obstructive CAD; cCTA—coronary CT angiography; CT-FFR—CT-derived fractional flow reserve; FN—false negative; FP—false positive; ICA—invasive coronary angiography; ML—machine learning; NPV—negative predictive value; PPV—positive predictive value; Sen.—sensitivity; Spe.—specificity; TN—true negative; TP—true positive; QCA—quantitative coronary analysis.
Table 2. Recategorization of patients without morphological signs of obstructive CAD with ML-based CT-FFR according to location.
Table 2. Recategorization of patients without morphological signs of obstructive CAD with ML-based CT-FFR according to location.
nFP (%)
Pat.10976 (70)
RCA10946 (42)
Seg. 11090 (0)
Seg. 21082 (2)
Seg. 310113 (13)
Seg. 47630 (39)
Seg. 168026 (33)
LM/Seg. 51090 (0)
LAD10953 (49)
Seg. 61090 (0)
Seg. 71099 (8)
Seg. 810850 (46)
Seg. 98811 (13)
Seg. 105611 (20)
Seg. 17343 (9)
CX10927 (25)
Seg. 111091 (1)
Seg. 12887 (8)
Seg. 13906 (7)
Seg. 14587 (12)
Seg. 15114 (36)
Seg. 18136 (46)
Recategorization with ML-based CT-FFR of patients without morphological signs of obstructive CAD on cCTA against ICA/QCA on patient, vessel and segment level. Note: 7 patients were excluded because of image quality or anatomic variants not suitable for ML-based CT-FFR. Thresholds for obstructive CAD were ≥50% diameter for cCTA and QCA and ≤0.80 for CT-FFR. Segment definition according to the 18-segment model [26]. CAD—coronary artery disease; cCTA—coronary CT angiography; CT-FFR—CT-derived fractional flow reserve; FP—false positive; ICA—invasive coronary angiography; Seg.—segment; QCA—quantitative coronary analysis.
Table 3. Group comparison and correlation between recategorization status and image quality parameters or CAC.
Table 3. Group comparison and correlation between recategorization status and image quality parameters or CAC.
VariablesTN (n = 31)FP (n = 76)pCorrelation
Coefficient
CIp
Contrast opacification (HU)510.9 ± 125.8487.3 ± 165.20.430.07−0.12, 0.260.48
CNR12.33 ± 3.6712.38 ± 4.190.94−0.007−0.20, 0.180.95
Image quality score2 (1)2 (1)0.740.03−0.15, 0.210.73
CACPatient343.4 (584.1)189.6 (538.1)0.100.16−0.03, 0.340.10
CACRCA47.2 (225.5)22.3 (80.1)0.390.08−0.11, 0.270.39
CACLAD42.6 (183.8)118.0 (315.1)0.04−0.20−0.38, −0.010.03
CACCX9.0 (80.4)9.6 (85.9)0.91−0.01−0.21, 0.190.91
Group comparison and correlation measures between image quality parameters or CAC on patient and vessel level and recategorization status from true negative (TN) to false positive (FP) with ML-based CT-FFR of patients without morphological signs of obstructive CAC. Thresholds for obstructive CAD were ≥50% diameter for cCTA and QCA and ≤0.80 for CT-FFR. For group comparisons (TN vs. FP) median (and IQR) (image quality score and CAC) or means ± SD (contrast opacification and CNR) are given for both groups, and Mann–Whitney U tests and t-tests were performed, respectively. Correlation coefficients and corresponding CIs were calculated using rank-biserial correlation (between recategorization status and image quality score or CAC) or point-biserial correlation (between recategorization status and contrast opacification or CNR). p-values of correlation coefficients correspond to the null hypothesis of the respective coefficient being zero. CAC—coronary artery calcium scoring; CAD—coronary artery disease; cCTA—coronary CT angiography; CI—confidence interval; CNR—contrast to noise ratio; CT-FFR—CT-derived fractional flow reserve; CX—circumflex artery; FP—false positive; HU—Hounsfield units; IQR—interquartile range; LAD—left anterior descending artery; RCA—right coronary artery; TN—true negative; SD—standard deviation; QCA—quantitative coronary analysis.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gohmann, R.F.; Seitz, P.; Pawelka, K.; Majunke, N.; Schug, A.; Heiser, L.; Renatus, K.; Desch, S.; Lauten, P.; Holzhey, D.; et al. Combined Coronary CT-Angiography and TAVI Planning: Utility of CT-FFR in Patients with Morphologically Ruled-Out Obstructive Coronary Artery Disease. J. Clin. Med. 2022, 11, 1331. https://doi.org/10.3390/jcm11051331

AMA Style

Gohmann RF, Seitz P, Pawelka K, Majunke N, Schug A, Heiser L, Renatus K, Desch S, Lauten P, Holzhey D, et al. Combined Coronary CT-Angiography and TAVI Planning: Utility of CT-FFR in Patients with Morphologically Ruled-Out Obstructive Coronary Artery Disease. Journal of Clinical Medicine. 2022; 11(5):1331. https://doi.org/10.3390/jcm11051331

Chicago/Turabian Style

Gohmann, Robin Fabian, Patrick Seitz, Konrad Pawelka, Nicolas Majunke, Adrian Schug, Linda Heiser, Katharina Renatus, Steffen Desch, Philipp Lauten, David Holzhey, and et al. 2022. "Combined Coronary CT-Angiography and TAVI Planning: Utility of CT-FFR in Patients with Morphologically Ruled-Out Obstructive Coronary Artery Disease" Journal of Clinical Medicine 11, no. 5: 1331. https://doi.org/10.3390/jcm11051331

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop